Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PPP2R5C |
| Upstream (Parents) |
|---|
| (<<) ADRBK2 → PPP2R5C |
| (<<) CBL → PPP2R5C |
| (<<) DLGAP3 → PPP2R5C |
| (<<) DYNC1LI2 → PPP2R5C |
| (<<) KCTD5 → PPP2R5C |
| (<<) KRAS → PPP2R5C |
| (<<) MAP2K2 → PPP2R5C |
| (<<) NR3C1 → PPP2R5C |
| (<<) RARG → PPP2R5C |
| (<<) SLC20A1 → PPP2R5C |
| (<<) SMURF1 → PPP2R5C |
| (<<) STK4 → PPP2R5C |
| Downstream (Children) |
|---|
| PPP2R5C → BAD (>>) |
| PPP2R5C → BMPR1A (>>) |
| PPP2R5C → CCND1 (>>) |
| PPP2R5C → CDK4 (>>) |
| PPP2R5C → DHCR7 (>>) |
| PPP2R5C → DOCK9 (>>) |
| PPP2R5C → FAM48A (>>) |
| PPP2R5C → FLJ35934 (>>) |
| PPP2R5C → FNBP1 (>>) |
| PPP2R5C → FOXA2 (>>) |
| PPP2R5C → GRPEL1 (>>) |
| PPP2R5C → HSPC159 (>>) |
| PPP2R5C → IL1A (>>) |
| PPP2R5C → INPPL1 (>>) |
| PPP2R5C → KCNJ5 (>>) |
| PPP2R5C → LIMK1 (>>) |
| PPP2R5C → LYPD5 (>>) |
| PPP2R5C → MAP3K3 (>>) |
| PPP2R5C → MBOAT2 (>>) |
| PPP2R5C → MMP17 (>>) |
| PPP2R5C → MVK (>>) |
| PPP2R5C → NCOA3 (>>) |
| PPP2R5C → NFAT5 (>>) |
| PPP2R5C → NFKBIZ (>>) |
| PPP2R5C → NRIP1 (>>) |
| PPP2R5C → NRSN2 (>>) |
| PPP2R5C → PAG1 (>>) |
| PPP2R5C → PCSK7 (>>) |
| PPP2R5C → PDE4C (>>) |
| PPP2R5C → PDPK1 (>>) |
| PPP2R5C → PLK1 (>>) |
| PPP2R5C → PRR7 (>>) |
| PPP2R5C → PTMS (>>) |
| PPP2R5C → RBL2 (>>) |
| PPP2R5C → RHOD (>>) |
| PPP2R5C → RORA (>>) |
| PPP2R5C → RPS6KA5 (>>) |
| PPP2R5C → SMAD5 (>>) |
| PPP2R5C → SYK (>>) |
| PPP2R5C → UBE2D3 (>>) |
| PPP2R5C → UBE2D4 (>>) |
| PPP2R5C → ZNF224 (>>) |
